REFERENCES
- Mellor SG, Rice P, Cooper GJ. Vesicant burns. Br J Plas Surg 1991; 44: 434–437.
- Chilcott RP, Jenner J, Hotchkiss SAM, Rice P. Evaluation of barrier creams against sulphur mustard: (I) In vitro studies using human skin. Skin Pharmacol Appl Skin Physiol 2002a; 15(4): 225–235.
- Liu DK, Wannemacher RW, Snider TH, Hayes TL. Efficacy of the topical skin protectant in advanced development. J Appl Toxicol 1999; 19: S41–S45.
- Chilcott RP, Dalton CH, Emanuel AJ, Allen C, Bradley S. Transepidermal water loss (TEWL) does not correlate with skin barrier function in vitro. J Investig Dermatol 2002b; 188:871–875.
- Chilcott RP, Brown RFR, Rice P. Non-invasive quantification of skin injury resulting from exposure to vesicating chemical vapours. Burns 2000a; 26: 245–250.
- Graham JS, Martin JL, Zallnick JE, Nalls CR, Mitcheltree LW, Lee RB, Logan TP, Braue EH. Assessment of cutaneous sulfur mustard injury in the weanling pig. Skin Res Tech 1999; 5: 56–67.
- Graham JS, Schomacker KT, Glatter RD, Briscoe CM Braue EH, Squibb KS. Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res Tech 2002; 8: 57–69.
- Chilcott RP, Stubbs B, Ashley Z. Habituating pigs for in-pen, non-invasive biophysical skin analysis. Lab Animals 2001; 35: 230–235.
- Pinnagoda J, Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. Contact Dermatitis 1990; 22: 164–178.
- Brown RFR, Rice P. Histopathological changes in Yucatan mini-pig skin following challenge with sulphur mustard. A sequential study of the first 24 h following challenge. Int J Path 1997; 78: 9–20.
- Brown RFR, Rice P. Histopathological changes in large white pigs following challenge with sulphur mustard. J Cell Pathol 1998; 3: 34–56.
- Brown RFR, Rice P, Bennet NJ. Histopathological changes in large white pig skin following following challenge with sulphur mustard and Lewisite. A sequential study of the first 24 hours following challenge. Burns 1998; 24: 692–698.
- Franz TJ. Percutaneous absorption: On the relevance of in vitro. J Invest Dermatol 1975; 64:190–195.
- Chilcott RP, Jenner J, Carrick W, Hotchkiss SAM, Rice P. In vitro human skin absorption of bis-2-(chloroethyl)sulphide (sulphur mustard). J Appl Toxicol 2000b; 20: 349–355.
- Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications; Florida: CRC Press, 1991.
- Rice P, Brown RFR, Lam DGK, Chilcott RP, Bennett NJ. Dermabrasion-a novel concept in the surgical management of sulphur mustard injuries. Burns 2000; 26: 34–40.
- Nagy SM, Golumbic C, Stein WH, Fruton JS, Bergmann M. The penetration of vesicant vapours into human skin. J Gen Physiol 1946; 29: 441–467.
- Renshaw B. Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In “Summary technical report of Division 9, NDRC Volume 1. Chemical warfare agents and related chemical problems.” Office of Scientific Research and Development, Washington, DC 1946.
- Maibach HI, Feldmann RJ, Milby TH, Serat WF. Regional variation in percutaneous penetration in man. Arch Environ Health 1971; 23: 208–211.
- Sawyer TW, Nelson P, Hill I, Conley JD, Blohm K, Davidson C. Therapeutic effects of cooling swine skin exposed to sulfur mustard. Mil Med 2002; 167: 939–943.
- Boman A, Mellström G. Percutaneous absorption of 3 organic solvents in the guinea pig (III). Effect of barrier creams. Contact Dermatitis 1989; 21: 134–140.
- Zhai H, Maibach HI. Effect of barrier creams: human skin in vivo. Contact Dermatitis 1996; 35:92–96.
- Fischer T, Rystedt I. Skin protection against ionized cobalt and sodium lauryl sulphate with barrier creams. Contact Dermatitis 1983; 9: 125–130.